It is approved by the U.S. Food and Drug Administration (FDA) for treating certain types of leukemia and is helpful in other conditions that
require immunosuppressive therapy.
Not exact matches
Similarly, ethical concerns often
require researchers to test drugs aimed at inducing tolerance in concert with
immunosuppressive therapy.
The immune rejection that complicates organ transplants, and normally
requires long - term
immunosuppressive drug
therapy, may also be treatable with CAAR T cell technology.